Heart Failure, Diastolic: Clinical Trials

26 trials for Heart Failure, Diastolic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 4 terminated, 3 withdrawn, 1 active not recruiting. 26 Phase 2, 4 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 226Completed 15, Terminated 4, Withdrawn 3, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1
Phase 14Completed 2, Not yet recruiting 1, Withdrawn 1
Phase 34Completed 2, Terminated 2

Follow Heart Failure, Diastolic: new trials by email Literature Review of Heart Failure, Diastolic trials Research Report on Heart Failure, Diastolic

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
Henggliflozin Combined with Probiotics, Henggliflozin, double placebo - Heart Failure, Preserved Ejection Fraction
Phase 1 / Phase 2Not yet recruitingThe First Affiliated Hospital of Air Force Medicial University1622026-07-012026-07-07
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
JK07 - HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction
Phase 2WithdrawnSalubris Biotherapeutics Inc2025-12-152026-05-15
Chronic Exogenous Ketosis in HFpEF
Exogenous Ketone Drink, Placebo - Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Normal Ejection Fraction
Phase 2Enrolling by invitationDuke University202025-07-282026-10-14
Allopurinol Improves Heart Function in African Americans With Resistant Hypertension
Allopurinol - Heart Failure Preserved Ejection Fraction, Resistant Hypertension
Phase 2CompletedVA Office of Research and Development402024-09-302026-09-04
Study of JK07 in Patients With Chronic Heart Failure
JK07, Placebo - Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction
Phase 2Active not recruitingSalubris Biotherapeutics Inc2822024-03-282026-05-22
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
Tovinontrine (CRD-750), Placebo - Heart Failure, Heart Failure Preserved Ejection Fraction
Phase 2CompletedCardurion Pharmaceuticals, Inc.3032024-02-132026-09-01
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
Low calorie meal replacement plan, Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography - Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic
Phase 2 / Phase 3CompletedUniversity of Leicester662023-12-052026-07-22
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
Sulforaphane - Diastolic Dysfunction, Systolic Dysfunction
Phase 1 / Phase 2WithdrawnTexas Tech University Health Sciences Center2022-07-012026-06-29
Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction
Dapagliflozin, Placebo - Heart Failure, Diastolic
Phase 2UnknownMariƫlle Scheffer262020-07-012020-09-22
CoQ10 and D-ribose in Patients With Diastolic Heart Failure
CoQ10, D-Ribose Oral Powder, Placebo pills - Heart Failure, Diastolic
Phase 2CompletedUniversity of Kansas Medical Center2162018-02-052022-03-18
Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCs
Allogeneic Derived Cells, Placebo/Control Arm - Congestive Heart Failure, Heart Failure, Diastolic
Phase 2CompletedCedars-Sinai Medical Center272017-07-122024-07-25
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
KNO3, KCl - Heart Failure, Diastolic Heart Failure
Phase 2CompletedUniversity of Pennsylvania122015-01-012017-10-03
Interleukin-1 Blockade in HF With Preserved EF
Anakinra, Placebo - Heart Failure With Normal Ejection Fraction
Phase 2CompletedVirginia Commonwealth University312014-09-012018-06-19
Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
Eplerenone, Placebo - Breast Cancer
Phase 2 / Phase 3TerminatedUniversity of British Columbia442014-05-012017-01-05
If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure
Ivabradine, Placebo - Diastolic Heart Failure
Phase 2WithdrawnSt Vincent's University Hospital, Ireland2012-12-012014-11-25
Inhaled Nitrite in Subjects With Pulmonary Hypertension
Inhaled Nitrite - Pulmonary Hypertension, Heart Failure, Diastolic
Phase 2CompletedSchmidhofer, Mark, MD482012-06-012019-03-28
Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction
renal denervation - Diastolic Heart Failure, Hypertension
Phase 2 / Phase 3TerminatedUMC Utrecht602012-04-012021-05-03
Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic Function
Echocardiography system Ultra DCI Model 5000, Echocardiography machine GE Vivid E9, Diastolic function assessment - Heart Failure, Diastolic
Phase 1 / Phase 2CompletedUniversity of Michigan502010-08-012023-10-16
Ranolazine in Diastolic Heart Failure
Ranolazine, Saline 0.9% and placebo tablet - Diastolic Heart Failure
Phase 2CompletedGilead Sciences202010-04-012012-07-12
Metoprolol XR in Heart Failure With Normal Ejection Fraction
Metoprolol XR - Diastolic Heart Failure
Phase 2CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1022010-01-012019-03-21

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Heart Failure (11)  ·  Hypertension, Pulmonary (3)  ·  Fibromatosis, Gingival, 2 (2)  ·  Heart Failure, Systolic (2)  ·  Hypertension (2)  ·  Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Breast Neoplasms (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Heart Diseases (1)  ·  Heart Murmurs (1)

Broader conditions

Cardiovascular Diseases (25)  ·  Heart Diseases (25)  ·  Heart Failure (15)  ·  Vascular Diseases (6)  ·  Lung Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Hypertension (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Arrhythmias, Cardiac (1)

Interventions

alagebrium (2)  ·  Allopurinol (1)  ·  Diagnostic Imaging (1)  ·  Diet (1)  ·  Echocardiography (1)  ·  Electrocardiography (1)  ·  Eplerenone (1)  ·  Hematologic Tests (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Ivabradine (1)  ·  Ketones (1)  ·  Perhexiline (1)  ·  Positron-Emission Tomography (1)  ·  Potassium Chloride (1)  ·  Probiotics (1)

Sponsors

Salubris Biotherapeutics Inc (2)  ·  Cardiovascular Clinical Sciences Inc (1)  ·  Cardurion Pharmaceuticals, Inc. (1)  ·  Cedars-Sinai Medical Center (1)  ·  Duke University (1)  ·  Gilead Sciences (1)  ·  MariĆ«lle Scheffer (1)  ·  Massachusetts General Hospital (1)  ·  Pfizer (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Schmidhofer, Mark, MD (1)  ·  St Vincent's University Hospital, Ireland (1)  ·  Synvista Therapeutics, Inc (1)  ·  Texas Tech University Health Sciences Center (1)  ·  The First Affiliated Hospital of Air Force Medicial University (1)

Countries

United States (14)  ·  Canada (4)  ·  Netherlands (3)  ·  United Kingdom (3)  ·  China (2)  ·  Germany (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Hungary (1)  ·  India (1)  ·  Ireland (1)  ·  Italy (1)  ·  New Zealand (1)

Top investigators

Antonio Abbate, MD, PhD (1)  ·  Benjamin Van Tassell, PharmD (1)  ·  Bertram Pitt, MD (1)  ·  Brandon Atkins (1)  ·  Dermot J McCaffrey, MB MRCPI FRACP (1)  ·  Gerry P McCann, MD (1)  ·  Janet Pierce, PhD (1)  ·  Julio A Chirinos, MD (1)  ·  Lars S. Maier, MD (1)  ·  Louis J Dell'Italia, MD (1)  ·  Marc A. Simon, MD (1)  ·  Marc J S, MD (1)  ·  Margot Davis, MD (1)  ·  Michael P Frenneaux, MBBS MD (1)  ·  Michael Zile, MD (1)

Results publications

PMID 21538388, PMID 21709061, PMID 23883653, PMID 24621836, PMID 24720918, PMID 25495811, PMID 27812547, PMID 27927683, PMID 28475816, PMID 29606104, PMID 30354558, PMID 35644694, PMID 39880434

NIH funding

2023 (1), I21RX004655 (1), R01AG054486 (1), R34HL118348 (1), R44HL071379 (1)